Antipsychotic Drugs Linked to Increased Mortality Among Parkinson's Disease Patients
Penn, University of Michigan, and VA-led Study Analyzed Medical Records of 15,000 Parkinson's Patients
At least half of Parkinson's disease patients experience psychosis at some point during the course of their illness, and physicians commonly prescribe antipsychotic drugs, such as quetiapine, to treat the condition. However, a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania, the University of Michigan Medical School, and the Philadelphia and Ann Arbor Veterans Affairs (VA) Medical Centers and suggests that these drugs may do significantly more harm in a subset of patients.More Research
UDALL IN THE NEWS
04/21/16Specialists have long suspected that symptoms progressed more slowly in Parkinson's disease patients whose main problem was tremors, rather than walking…
03/16/16In continuing coverage, the Philadelphia Inquirer reports on recent research showing that Parkinson's patients are disproportionately likely to have depression,…
03/16/16The use of antipsychotic (AP) medication to treat psychosis in Parkinson's disease (PD) increases the risk for all-cause death, and the risk varies with…
© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team.